BioSenic S.A. (0R55.L)

EUR 0.0

(0.0%)

Revenue Summary of BioSenic S.A.

  • BioSenic S.A.'s latest annual revenue in 2023 was 543 Thousand EUR , up 104.14% from previous year.
  • BioSenic S.A.'s latest quarterly revenue in 2024 Q2 was 1.34 Million EUR , down 0.0% from previous quarter.
  • BioSenic S.A. reported a annual revenue of 266 Thousand EUR in annual revenue 2022, down -73.4% from previous year.
  • BioSenic S.A. reported a annual revenue of 1 Million EUR in annual revenue 2021, down 0.0% from previous year.
  • BioSenic S.A. reported a quarterly revenue of 1.34 Million EUR for 2024 Q1, up 1413.48% from previous quarter.
  • BioSenic S.A. reported a quarterly revenue of 89 Thousand EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Revenue Chart of BioSenic S.A. (2023 - 2012)

Historical Annual Revenue of BioSenic S.A. (2023 - 2012)

Year Revenue Revenue Growth
2023 543 Thousand EUR 104.14%
2022 266 Thousand EUR -73.4%
2021 1 Million EUR 0.0%
2020 1 Million EUR 0.0%
2019 - EUR -100.0%
2018 1 Million EUR 2339.02%
2017 41 Thousand EUR 0.0%
2016 - EUR 0.0%
2015 - EUR 0.0%
2014 - EUR 0.0%
2013 - EUR 0.0%
2012 - EUR 0.0%

Peer Revenue Comparison of BioSenic S.A.

Name Revenue Revenue Difference
Boiron SA 493.24 Million EUR 99.89%
Laboratorios Farmaceuticos Rovi, S.A. 829.5 Million EUR 99.935%
Vetoquinol SA 529.27 Million EUR 99.897%
Valneva SE 153.71 Million EUR 99.647%
AB Science S.A. 970 Thousand EUR 44.021%
Nanobiotix S.A. 30.05 Million EUR 98.193%
PHAXIAM Therapeutics S.A. 1.32 Million EUR 59.05%
Vivoryon Therapeutics N.V. -3.62 Million EUR 115.0%
ABIVAX Société Anonyme 4.62 Million EUR 88.249%
Formycon AG 77.69 Million EUR 99.301%